Search Orphan Drug Designations and Approvals
-
Generic Name: | saracatinib |
---|---|
Date Designated: | 03/11/2019 |
Orphan Designation: | Treatment of idiopathic pulmonary fibrosis |
Orphan Designation Status: | Designated |
FDA Orphan Approval Status: | Not FDA Approved for Orphan Indication |
Sponsor: |
AstraZeneca Pharmaceuticals, LP Emerging Innovations, AstraZeneca, R&D Boston 35 Gatehouse Drive Waltham, Massachusetts 02451 United States The sponsor address listed is the last reported by the sponsor to OOPD. |
*Data for the Date Designation Withdrawn or Revoked field are shown for designations withdrawn or revoked after 08/12/2013.
-